On the morning of November 3, Working Conference and Cooperation Signing Ceremony for Joint Development of the In Vitro Diagnostic National Standards was held in Taizhou China Medical City. Lu Yong, the president of National Institutes for Food and Drug Control, Lu Chunyun, the member of Standing Committee of Taizhou Municipal Party Committee and the secretary of Party Working Committee of Medicine Hi-tech Zone, Wang Yue, the director of Jiangsu Food and Drug Administration as well as other leaders attended the signing ceremony. National Institutes of Food and Drug Control, Medical Device Inspection Institute of Jiangsu Province, Taizhou Medicine High-tech Zone Branch of Jiangsu Province Food and Drug Administration,three parities signed the “Memorandum of Joint Development of In Vitro Diagnostic National Standards". Taizhou ZECEN Biotech Co., Ltd is honored to participate in the development of in vitro diagnostic national standards for the gonadal hormones, cardiac markers, inflammation test and etc.

After the conference, President Lu Yong and his entourage visited ZECEN Company accompanied by Liu Zhenguo, general manager of ZECEN. General Manager Mr. Liu warmly welcomed the arrival of leaders and made a brief introduction of recent development and future development direction of the company. Besides, both parties had deep exchange on “Taizhou Model"of In Vitro Diagnosis. 

During the visit, President Lu Yong occasionally encountered ZECEN’s customer from Iran who was learning the new product of ZECEN.It is his third visit to ZECEN. He witnessed ZECEN’s developing from nothing and from small to large. He praised the environment and advanced equipment of ZECEN's production base, expressed his absolute affirmation and trust in the products made by ZECEN and will conduct further cooperation in various aspects with ZECEN in the future.

President Lu Yong expressed his admiration for the achievements made by ZECEN Biotech. He hoped that ZECEN could firmly seize this opportunity and make efforts to enhance the research and development capabilities and product technology content, and to build itself into a benchmark enterprise in China Medical City and even the whole country, and to promote the whole IVD industry to a new level by giving a full play to the exemplary.